spinraza
biogen netherlands b.v. - nusinersen natrium - muskelatrofi, spinal - andre narkotika stoffer - spinraza er indiceret til behandling af 5q spinal muskelatrofi.
evrysdi
roche registration gmbh - risdiplam - muskelatrofi, spinal - andre midler mod forstyrrelser i muskel-skeletsystemet - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.
diprivan 20 mg/ml injektions-/infusionsvæske, emulsion
aspen pharma trading limited - propofol - injektions-/infusionsvæske, emulsion - 20 mg/ml
diprivan 10 mg/ml injektions-/infusionsvæske, emulsion
aspen pharma trading limited - propofol - injektions-/infusionsvæske, emulsion - 10 mg/ml
nimbex 2 mg/ml injektionsvæske, opløsning
aspen pharma trading limited - cisatracuriumbesilat - injektionsvæske, opløsning - 2 mg/ml
isofluran "baxter" væske til inhalationsdamp
baxter a/s - isofluran - væske til inhalationsdamp
qaialdo
nova laboratories ireland limited - spironolacton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.
sevofluran "baxter" 1 ml/ml væske til inhalationsdamp
baxter a/s - sevofluran - væske til inhalationsdamp - 1 ml/ml
naropin 2 mg/ml infusionsvæske, opløsning
aspen pharma trading limited - ropivacainhydrochlorid (vandfri) - infusionsvæske, opløsning - 2 mg/ml
naropin 10 mg/ml injektionsvæske, opløsning
aspen pharma trading limited - ropivacainhydrochlorid (vandfri) - injektionsvæske, opløsning - 10 mg/ml